No Apparent Short-Term Cancer Risk From Recalled Valsartan

THURSDAY, Sept. 13, 2018 -- Users of valsartan contaminated with N-nitrosodimethylamine (NDMA) seem not to have increased cancer risk, according to a study published online Sept. 12 in The BMJ. Anton Potteg ård, Ph.D., from the University of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news